WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma — New Study While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
-
When Drinking Water Raises Bigger Questions About Brain Health And Environmental Risk A new study linking certain groundwater sources to higher Parkinson’s risk underscores a broader question for the water sector: how environmental exposures in drinking water may influence long-term health.
-
EPA Seeks Court‑Ordered Removal Of 4 PFAS Limits The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
-
Putting The National Toxicology Program's Fluoride Review In Context Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
Opinion: Why PFAS Policymakers Should Read Past The Abstract When it comes to drinking water, sound public policy requires sound scientific research. Publication in a prestigious, peer-reviewed journal helps establish legitimacy for scientific claims in public discourse. But science is a social process, scientific standards of evidence vary across disciplines, and peer review does not guarantee validity. For readers who stop at the abstract, these distinctions can be easy to miss.
-
Planting The Seeds Of Inspiration: Eelgrass Restoration
Restoring eelgrass beds is critical because they provide habitat for many kinds of marine life, improve water quality by filtering out pollution, and the plant’s root system stabilizes the sediment on the seafloor, protecting shorelines from erosion.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
Ozone is a vital pre-treatment for PFAS mitigation. It oxidizes precursors and co-contaminants, significantly extending the service life of downstream GAC and membrane systems.
-
Digital water twins integrate real-time data to create dynamic simulations of physical networks. This collaborative technology empowers teams to visualize system behavior, predict potential issues, and optimize operations for improved reliability and resource management.
-
CMMS and EAM go-lives in GMP environments hinge on more than timing. Explore how big-bang, phased, compliance-first, and patchwork approaches shift validation effort, audit risk, and operational strain.
-
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
-
Emerging state water reuse regulations are driving adoption of ozone and advanced oxidation, requiring flexible, high-performance systems to meet pathogen, trace organic, and DBP control objectives.
-
Read about three of the most pressing wastewater challenges utilities face today and how Stratmoor Hills, Key West Resort Utilities, and Beijing Water Group are using advanced treatment and reuse to overcome them.
-
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
What's really at stake when choosing between surface water and groundwater? The answer shapes water security for decades.
-
Recent federal PFAS regulations will overwhelm consulting engineers, water and wastewater utilities, and equipment manufacturers as thousands of utilities work to comply. Generative design can enable these parties to meet the workload demand and deadlines.
-
This article will explore five common misconceptions about GAC and IX technologies for PFAS removal, helping utilities choose effective, site-specific treatment strategies for contaminated drinking water.
-
This resource will help you navigate the complexities of industrial and municipal wastewater treatment, understand the latest technology, and see how Aria Filtra® technology addresses the needs of modern wastewater management.
-
Focusing on lifecycle ROI reveals ozone's value. It significantly reduces chemical and operational costs while extending filter media life, providing measurable long-term financial savings and compliance resilience.
-
PFAS rules are shifting fast. Learn how utilities can futureproof treatment strategies with flexible designs, smart staging, and emerging technologies—avoiding stranded assets and staying ahead of tomorrow’s regulations.
-
Explore the tax implications for individuals who received compensation for participating in clinical trials, specifically focusing on the issuance of the 1099-MISC.
-
Producing high-quality oligonucleotides demands precise execution across multiple stages. Gain a clearer understanding of the complete mid-scale production workflow and necessary quality control measures.
-
Single-future design assumptions are no longer sufficient. See what scenario modelling reveals about building treatment infrastructure that performs across decades of uncertainty.
-
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Antibody–drug conjugates combine monoclonal antibodies, linkers, and potent cytotoxins, requiring highly sensitive analytics, stringent cleaning validation, and flexible platforms to manage manufacturing complexity and contamination risks.